ID 110830
著者
セイケ, ジュンイチ Department of Oncological and Regenerative Surgery, Institute of Health Bioscience, The University of Tokushima Graduate School
ヨシダ, タカヒロ Department of Oncological and Regenerative Surgery, Institute of Health Bioscience, The University of Tokushima Graduate School 徳島大学 教育研究者総覧 KAKEN研究者をさがす
ホンダ, ジュンコ Department of Oncological and Regenerative Surgery, Institute of Health Bioscience, The University of Tokushima Graduate School
ミヨシ, タカノリ Department of Oncological and Regenerative Surgery, Institute of Health Bioscience, The University of Tokushima Graduate School
ウメモト, アツシ Department of Oncological and Regenerative Surgery, Institute of Health Bioscience, The University of Tokushima Graduate School
丹黒, 章 Department of Oncological and Regenerative Surgery, Institute of Health Bioscience, The University of Tokushima Graduate School 徳島大学 教育研究者総覧 KAKEN研究者をさがす
キーワード
esophageal cancer
chemotherapy
lung metastasis
資料タイプ
学術雑誌論文
抄録
A 55-year-old-male patient underwent subtotal esophagectomy for esophageal cancer (pT1b, N0, M0, stage II) in April 2005. The patient received postoperative chemotherapy (docetaxel 40 mg/body, 5-fluorouracil 750 mg/body, cisplatin 10 mg/body : administered every 4 weeks) for 3 months. Six months postoperatively, routine follow up CT demonstrated multiple metastatic tumors in the bilateral lungs. Under the diagnosis of multiple lung metastases, the patient was hospitalized and received intensive chemotherapy with docetaxel 40 mg/ week (day 1), 5-fluorouracil 500 mg/ day (days 1-5), cisplatin 10 mg/ day (days 1-5). After two weeks administration, the patient eagerly hoped for outpatient treatment. The treatment was changed to outpatient chemotherapy with S-1 100 mg/ day (continuous administration for 3 weeks followed by rest for 1 week) and cisplatin 20 mg/ every week. The treatment enabled the patient to keep working. Follow up CT showed disappearance of all tumors two months after TS-1/cisplatin chemotherapy. There were no obvious signs of recurrence 5 months after chemotherapy. The S-1/cisplatin therapy in the outpatient was thought to be one of the effective treatments in maintaining quality of life for the patient.
掲載誌名
The journal of medical investigation : JMI
ISSN
13431420
cat書誌ID
AA11166929
53
3-4
開始ページ
321
終了ページ
324
並び順
321
発行日
2006-08
EDB ID
フルテキストファイル
言語
eng
著者版フラグ
出版社版
部局
病院
医学系